Facundo Zaffaroni Selected Research

Facundo Zaffaroni Research Topics

7	Neoplasms (Cancer) 06/2022 - 01/2018
4	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2018
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2022 - 01/2020
2	Fatigue 01/2020 - 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Nausea 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Stomatitis 01/2020
1	Rupture 01/2020
1	Vomiting 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Weight Gain 05/2019
1	Adenocarcinoma 05/2019
1	Osteoporosis 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019

2	cabozantinibIBA 06/2022 - 01/2020
2	Phenobarbital (Luminal)FDA Link 10/2020 - 11/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2020
1	LigandsIBA 11/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	ORALIT (ORS)IBA 10/2019
1	apalutamideIBA 05/2019
1	Abiraterone AcetateIBA 05/2019
1	Testosterone (Sustanon)FDA Link 05/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019

4	Therapeutics 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2019
1	Radiotherapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Drug Tapering 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Castration 05/2019
1	Consolidation Chemotherapy 01/2018